Sponsored Clinical Trials and Bias
J Clin Psychiatry 2007;68:1621-1622 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: I read with great interest your editorial1 and the 2 letters from the February 2007 issue of your journal2,3 highlighting the important concern about the source of funding influence on the outcome of interest.
In addition to the recent review by Heres et al.4 that you refer to in your editorial,1 the relationship between funding source and study outcome, which is so beautifully illustrated by the exchange between your 2 correspondents,2,3 was investigated in several other published studies.5–15 With one exception,11 these studies showed that industry support was uniformly associated with positive study outcome for the sponsored intervention either as a trend8 or, most times, at significant levels.5,6,9,10,12–15